Ultralife Corporation designs, manufactures, installs, and maintains power and communications systems for government, defense, and commercial sectors worldwide. The company operates through two segments, Battery & Energy Products and Communications Systems. The company was founded in 1990 and is based in Newark, New York.
ULBI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Ultralife Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Ultralife Corp ranked in the 85th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 1012.5% on a DCF basis. As for the metrics that stood out in our discounted cash flow analysis of Ultralife Corp, consider:
The company's balance sheet shows it gets 97% of its capital from equity, and 3% of its capital from debt. Its equity weight surpasses that of 90.39% of free cash flow generating stocks in the Industrials sector.
The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately merely 12.3% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Ultralife Corp? See AENZ, FLY, HIL, CPA, and LXFR.
Ultralife Corporation (ULBI) Q2 2020 Earnings Conference Call July 30, 2020 08:30 A.M. ET Company Participants Jody Burfening - Lippert/Heilshorn & Associates, Inc. Michael D. Popielec - CEO and President Philip A. Fain - CFO, Treasurer, and Corporate Secretary Conference Call Participants Gary Siperstein - Eliot Rose Asset Management Presentation...
NEWARK, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $2.3 million on revenue of $28.6 million for the second quarter ended June 30, 2020. For the second quarter of 2019, the Company reported operating income of $3.0 million on revenue of $29.4 million. “Ultralife’s second quarter adjusted earnings per share of $0.13 cents reflects the benefits of our end-market diversity and resilient business model in the face of continued business disruptions caused by the pandemic,” said Michael D. Popielec, President and Chief Executive Officer. “Our Battery and Energy Products’ medical sales and government/defense sales increased 72% and 50% year over year, respectively, and when combined with the contribution from SWE, nearly offset Com...
Ultralife Corporation (NASDAQ: ULBI) today announced that due to the ongoing public health impact of the coronavirus (COVID-19) pandemic and out of an abundance of caution, the location of the Annual Meeting of Shareholders to be held on July 22nd at 9:00 AM Eastern Time will be changed to the Newark, NY headquarters of Ultralife located at 2000 Technology Parkway, Newark, NY 14513. As described in the proxy materials for the Annual Meeting previously distributed, shareholders are entitled to vote at the Annual Meeting if they were a shareholder at the close of business on May 26, 2020, the record date. For additional information regarding how shareholders may vote in advance of or at the Annual Meeting, please refer to Ultralife’s proxy materials filed with the U.S. Securities and E...